The regulatory file for elastin peptides
Elastin peptides come from animal tissue, so the regulatory file begins with the species and the tissue rather than with the protein figure. The destination sets the route, and the buyer's regulatory team confirms it for the material, the source and the use. What follows is the document set and the checks behind it.
The specification describes the powder; the regulatory file shows the source, the route and the label for the destination.
What the file has to settle
A regulatory file has to answer four things: which material and which specification version are being bought; which lot is on the certificate; which route, contaminant limits and label rules apply where the product will be sold; and what has to be re-opened if the tissue, the plant or the pack changes. The COA speaks to the lot, the technical data sheet to the specification and the safety data sheet to handling. None of the three settles the route.
Animal-derived material adds documents. Species, tissue and country of origin have to be declared, with an allergen statement for fish material, a TSE statement for bovine material and a change-control route for any source change. A new tissue is a new specification, not a purchasing detail.
European Union
The first question is whether this exact material has a documented history of consumption in the EU before 15 May 1997. If not, Regulation (EU) 2015/2283 applies and a novel-food authorisation may be required before sale. The question is material-specific: egg membrane hydrolysate, whose proteins are mainly elastin and collagen, has been assessed under that framework, which shows that the answer turns on the tissue and the process rather than on the word “elastin”.
Labelling sits under Regulation (EU) No 1169/2011. Fish is an Annex II allergen, so fish-derived elastin must be declared; an egg-membrane source brings the egg allergen instead. Bovine material needs the TSE file under Regulation (EC) No 999/2001, with species and tissue stated. Contaminants are checked against Regulation (EU) 2023/915 at the finished-product dose, and claims against Regulation (EC) No 1924/2006.
United States
In the US the file follows the dietary ingredient and its intended use. The supplier states the basis it relies on and cites the document behind it; the buyer checks that the basis reaches the ingredient, the tissue and the finished product. A new dietary ingredient notification is one possible route, not a blanket requirement. Manufacturing sits under 21 CFR 111, and the Supplement Facts panel under 21 CFR 101.36.
Fish is a major allergen under US labelling, so fish-derived elastin is declared; an egg source brings egg. Bovine material raises the BSE question and the origin paperwork. State rules can add thresholds; California's Proposition 65 is the one most often assessed for lead and cadmium.
Contaminants and limits
Contaminants are judged at the finished-product level, not only in the drum. The figures below are a starting point for a supplement file: the destination text in force and the daily dose fix the final limit.
| Contaminant | Common supplement limit | Evidence the file needs |
|---|---|---|
| Lead (Pb) | 3.0 mg/kg in the supplement | Lot figure, method, limit and the dose calculation |
| Cadmium (Cd) | 1.0 mg/kg in the supplement | Lot figure and any category exception that applies |
| Mercury (Hg) | 0.10 mg/kg in the supplement | Lot figure and method |
| Arsenic (As) | Customer or market limit | The agreed limit, the method and the result |
The drum figure has to be carried through the serving size, so the reviewer needs the calculation, not only the raw number. A result without its method cannot be compared with a limit. Ask for each element separately; a combined metals total hides the one that matters.
Claims and label wording
The ingredient, its quantity and its source must appear on the label in the form the destination prescribes. Claim review is a separate exercise. In the EU a health claim must be authorised and used under its conditions; in the US a structure-function claim has its own wording and notification route. Neither permits a disease claim, and a certificate never approves a claim.
Composition wording — protein, peptide content, source — should be supportable from the specification. Wording about an effect in the body is a claim and belongs to the brand's reviewer. Keep the two apart on the pack.
The document set
Before a first order, the file should hold the specification, the lot COA, the technical data sheet, the safety data sheet, the allergen statement, the species and tissue declaration, the country of origin and, for bovine material, the TSE/BSE statement. Add the GMO statement, the residual-solvent statement and any declaration the importer asks for.
Date or version every document. The offer, the specification and the certificate should point to the same version. Undated PDFs are not a file, and a statement that cannot be tied to a lot describes a product family, not a drum.
Checklist before the first order
- The specification version, the species and the tissue are written down.
- COA, TDS, SDS and the allergen, origin, TSE/BSE and GMO statements sit in the file.
- Each contaminant result has been recalculated at the finished-product dose.
- The buyer's regulatory team has confirmed the route for the destination.
- Label and claim wording has been reviewed for that destination.
- Source, process and pack sit under a change-control procedure.
The catalogue ranges sit on the elastin peptides product page; the lot certificate is explained on the COA page; the analytical evidence is on the identity page; the EU framework is summarised in the regulatory notes; the quality page describes the release file.
Related documents
Send the specification you intend to use — grade, quantity and destination market — and we will reply with the batch COA, the technical data sheet and a quotation.
Request a quotation